Engerix-B 58160-0821
Generic: Hepatitis B Vaccine (recombinant)
Product NDC
58160-0821- Manufacturer
- Glaxosmithkline Biologicals Sa
- Dosage Form
- Injection, Suspension
- Route
- Intramuscular
- Product Type
- Vaccine
- Marketing Start
- March 28, 2007
- Listing Expires
- December 31, 2027
- Application
- BLA103239
Active Ingredients
| Ingredient | Strength |
|---|---|
| Hepatitis B Virus Subtype Adw2 Hbsag Surface Protein Antigen | 20 ug/mL |
Packaging Options(2)
10 VIAL in 1 CARTON (58160-821-11) / 1 mL in 1 VIAL (58160-821-01)
10 SYRINGE in 1 CARTON (58160-821-52) / 1 mL in 1 SYRINGE (58160-821-43)